At the end of their cycle, hematocrit amounts experienced increased by three%-position when compared with baseline. The rise was not connected with for a longer period use or larger AAS dose. A cause for this may very well be that, outside of a specific degree of androgenic action, no further more enhance of hematocrit happens: a ‘ceiling effect�